Comprehensive Tobacco Treatment: Moving Beyond One-Size-Fits-All Care

This article was written by Arnelle Konde, MPH, CHES.

Smoking and tobacco exposure are primary risk factors for chronic obstructive pulmonary disease (COPD) progression and mortality, accounting for up to 80% of COPD-related deaths in the United States.¹ People with disabilities (e.g., individuals who have physical, cognitive, psychiatric and sensory impairments) have disproportionately higher rates of tobacco use and suffer worse health outcomes as a result.² Addressing this disparity requires comprehensive, evidence-based tobacco treatment that combines counseling, pharmacotherapy, and ongoing follow-up support.² As tobacco patterns continue to evolve with products such as e-cigarettes and vaping^3,4, health care must provide patient-centered, inclusive treatment that is accessible for all patients.

Evidence-Based Strategies for Tobacco Treatment

Previous studies on tobacco treatment suggest that the most effective interventions involve a combination of approaches.⁵ Evidence-based strategies to tobacco treatment include:

• Behavioral Counseling: Cognitive behavioral therapy, motivational interviewing, and structured cessation programs help patients identify triggers and build coping mechanisms.^5,6
• Nicotine Replacement Therapy (NRT): Short-acting and long-acting options provide controlled doses of nicotine to manage withdrawal symptoms.^7,8 These can include:
  • Patches
  • Gum
  • Lozenges
  • Inhaler
  • Nasal spray
• Prescription Pill Medications: Non-nicotine oral medications target nicotine receptors in the brain to reduce nicotine cravings. The FDA has approved the following medications to help individuals stop smoking:^4,8
  • Varenicline⁸
  • Bupropion SR⁸

In practice, people achieve higher long-term quit rates when their treatment consists of pairing behavioral counseling with a tailored combination of NRT and prescription therapies.^5,8

Vaping and E-Cigarettes

Nicotine dependence is a chronic, relapsing condition directly linked to both traditional tobacco products and e-cigarettes.^3,4 Although many adults use e-cigarettes to help them quit smoking, these devices often transition users into a new cycle of dependence.⁴ As a result, e-cigarette and vaping cessation has become a priority for preventing long-term lung health problems.

However, vaping cessation comes with its own challenges:

• High nicotine concentrations: Many modern vape products may deliver significantly higher nicotine levels than traditional cigarettes.⁴
• Dual use: Some patients may use both regular cigarettes and e-cigarettes simultaneously rather than switching entirely.⁴
• The "Harmless" Myth: The widespread belief that vaping is not as harmful as cigarette smoking can reduce a patient's motivation to quit.^1,4

Recognizing these specific challenges allows health care professionals to design more effective, realistic quit plans for patients who vape.

Tobacco Treatment for Individuals with Disabilities

Individuals with disabilities have disproportionately high rates of tobacco use.⁹ Additionally, data has shown that individuals with disabilities also have higher rates of e-cigarette use.9 However, standard treatment programs are rarely designed to address their specific needs.⁵ Some traditional treatment programs may be ineffective for this population because they do not consider these unique challenges. For example, standard clinical advice like taking a walk or practicing deep breathing to manage nicotine cravings may not be feasible for those with physical or respiratory limitations.⁵ Furthermore, some traditional treatment programs have lacked accommodations for patients with communication barriers.¹⁰

To provide truly equitable care, clinicians must adapt their approach to navigate these unique barriers. Tailored interventions for individuals with disabilities include:

• Accessible Communication and Materials: Ensure print or digital resources accommodate sensory and cognitive variations. This includes utilizing plain-language schedules for individuals with intellectual disabilities, providing screen-reader-compatible apps, or offering visual aids for deaf or hard-of-hearing patients.¹⁰
• Involvement of Support Networks: Effective treatment should extend beyond the patient. Integrating caregivers, personal care attendants, and family members into the counseling process ensures consistent reinforcement of the treatment plan and better NRT adherence.¹¹
• Flexibility in Program Delivery: Clinicians should opt for flexible tracking mechanisms such as using text-based check-ins, telehealth counseling, or peer-support groups. This can reduce the logistical burdens of frequent, in-person clinical follow-ups.¹¹

By deliberately modifying how these interventions are delivered, health care systems can ensure that tobacco treatment is both clinically effective and universally accessible.

Comprehensive tobacco treatment requires moving past a one-size-fits-all approach. Clinicians and health care organizations can improve outcomes by addressing physical, communication, and technological barriers. Accessible, patient-centered tobacco treatment can help more people quit smoking and vaping, improve health outcomes, and promote better long-term health.

To learn more about implementing disability-inclusive care in your practice, explore the clinical resources and tools available through the Disability Network for Tobacco Control and Cancer Prevention Community of Practice.